Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
Addiction2020Vol. 116(5), pp. 1000–1010
Citations Over TimeTop 1% of 2020 papers
Tom P. Freeman, Sam Craft, Jack Wilson, Stephan Stylianou, Mahmoud A. ElSohly, Marta Di Forti, Michael T. Lynskey
Abstract
Concentrations of delta-9-tetrahydrocannabinol (THC) in international cannabis markets increased from 1970 to 2017 while cannabidiol (CBD) remained stable. Increases in THC were greater in cannabis resin than herbal cannabis. Rising THC in herbal cannabis was attributable to an increased market share of high-THC sinsemilla relative to low-THC traditional herbal cannabis.
Related Papers
- → An efficient new cannabinoid antiemetic in pediatric oncology(1995)183 cited
- → Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the “weed,” a pharmacodynamic discussion(2016)18 cited
- → Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study(1993)179 cited
- → Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effects(1976)123 cited
- → The effect of delta-9-tetrahydrocannabinol and cannabidiol on p50 of the oxygen haemoglobin dissociation curve(2020)2 cited